Jupiter Neurosciences (JUNS) - Stock Quotes
Jupiter Neurosciences Inc (JUNS) is a biotech player developing advanced medications to combat dementia and cognitive impairment. Business growth relies on the success of oral resveratrol (Jotrol) and the pursuit of investments from major pharma behemoths. This asset value chart on GURU.Markets, where the metric is fixed at 1.87, illustrates a period of capital expenditure on costly clinical trials prior to the product's market launch.
jupiterneurosciences.com (JUNS) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- market capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
Debt to Equity Jupiter Neurosciences Inc|JUNS - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Jupiter Neurosciences|JUNS - Company Cumulative Debt|Debt to Book Value Jupiter Neurosciences, Inc.|JUNS - Company Long-Term Debts|Company Short-Term Debt Jupiter Neurosciences|Quick Liquidity jupiterneurosciences.com
- company profitability and valuation multiples indicators:
JUNS - Company Net Income|Expected Profit Jupiter Neurosciences Inc|JUNS - Market Price to Net Income Ratio|Projected Price to Earnings Jupiter Neurosciences Inc|JUNS - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Jupiter Neurosciences, Inc.|JUNS - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) Jupiter Neurosciences|JUNS - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months jupiterneurosciences.com|JUNS - Net earnings per one share growth for the current year|Earnings growth forecast for next year Jupiter Neurosciences Inc
Analysis of all company metrics:Jupiter Neurosciences Inc JUNS
The price represents the market equivalent of a single share's value, reflecting the current balance of demand and the asset's overall investment attractiveness. Analyzing the price action history allows for an assessment of portfolio resilience to volatility, confirming the capitalization of Jupiter Neurosciences Inc (JUNS) through the readiness of its production facilities and laboratories to scale the output of neurological drugs.
Analysis of competing companies
Price Chart Biogen Inc. (BIIB)|Price NBIX|Regencell Bioscience Holdings Limited - Stock Quotes|Stock Price Axsome AXSM|ACAD - Price Chart|XENE (Xenon Corp) - Share Price|Viking Therapeutics (VKTX) - Price Chart|SUPN - Market Chart|Price Chart Catalyst Pharmaceuticals, Inc.|Share Price DNLI (Denali)|Stock Price HRMY|BHVN - Market Price|Amylyx Pharmaceuticals - Stock Quotes|Stock Price trevitherapeutics.com TRVI|PRAX - Price Chart|Price Performance Chart AVXL (Anavex)|CeriBell Corp (CBLL) - Price Chart|Market Price Prothena Corporation plc (PRTA)|Price Chart Alector Inc.|ANNX (annexonbio.com) - Price|Stock Quotes OMER (Omeros Corporation)|Stock Price Neurogene Inc (NGNE)|Price Chart AC Immune Corp ACIU|VYGR (Voyager Corp) - Quote Chart|Neumora Therapeutics - Stock Price|Market Chart scilexholding.com SCLX|TVGN (Tevogen Bio) - Stock Quotes|ACOG: Price|CGTX (Cognition Therapeutics) - Stock Price|Market Price Inhibikase Pharma IKT|Price Chart Cassava Sciences, Inc. (SAVA)|ASRT (assertiotx.com) - Price Performance Chart|Coya Therapeutics - Stock Quotes|Price Performance Chart VTGN|OVID - Price Chart|ABOS (Acumen Pharmaceuticals, Inc) - Share Price|CRVO: Stock Price|Market Price Alterity Therapeutics Limited (ATHE)|Stock Quotes CLNN|Stock Price PepGen Corp|Price Chart Relmada (RLMD)|ANVS (Annovis Bio Corporation) - Price Performance Chart|Price Chart Grace Therapeutics GRCE|fireflyneuro.com (AIFF) - Market Price|KLTO - Price Chart|Market Chart NeuroSense Therapeutics NRSN|RVPH: Stock Price|Stock Quotes MetaVia|NRXS (NeurAxis, Inc.) - Stock Price|Helius Medical Technologies Inc. (HSDT) - Market Chart|Stock Price PASG|NEUP - Market Price|Price Chart Minerva Neurosciences Corp NERV|ATHA: Share Price|Addex Therapeutics - Stock Price|Alzamend Neuro, Inc. (ALZN) - Stock Quotes|CYCN: Stock Price|Market Price Protagenic Therapeutics, Inc. (PTIX)|Price Chart Pasithea Therapeutics Corp|Cortigent Medical (CRGT) - Market Chart|Stock Quotes ATXI (Avenue Therapeutics)|BCLI (brainstorm-cell.com) - Price Performance Chart|Stock Price CARA (Cara Therapeutics)|Market Chart Chromocell Therapeutics Corp (CHRO)|ELYM - Price Chart|ITCI (Intra-Cellular Therapies) - Share Price|LBPH: Stock Price|Stock Quotes marinuspharma.com|Price Chart NKGen Biotech|NRBO (NeuroBo Pharmaceuticals Inc) - Price|Stock Quotes SAGE (Sage Therapeutics, Inc)|Stock Price Synaptogenix, Inc (SNPX)|Price Chart Trevena, Inc. TRVN|VIGL: Share Price|WENA - Price Chart|Market Chart Cerevel Therapeutics Inc CERE
